icon-folder.gif   Conference Reports for NATAP  
 
  19th European AIDS Conference
October 18th-21st , 2023
Warsaw, Poland
Back grey_arrow_rt.gif
 
 
 
Safety, pharmacokinetics, and exploratory efficacy of the PD-1 inhibitor budigalimab in antiretroviral treatment-suppressed people living with HIV-1: preliminary analysis of 2 Phase 1b studies including an analytical treatment interruption
 
 
  oral at EACS 2023 Oct 20

1024231

1024232

1024233

1024234

1024235

1024236

1024237